Studio E.R. Congressi
With the unrestricted educational grant of:

PATHOPHYSIOLOGY OF AA AND PNH

Chairs: G. Di Minno, A.M. Risitano

Special Lecture: Pathophysiology of Aplastic Anemia and PNH: what we know and what we don’t yet know
L. Luzzatto
The immune system and telomeres in AA
R.T. Calado

SOMATIC MUTATIONS IN BONE MARROW FAILURE SYNDROMES

Chairs: M. Cazzola, G. Pizzolo

Somatic mutations in AA
A.G. Kulasekararaj
Debate: is PNH a myeloid malignancy? No
A.M. Risitano

NON-TRANSPLANT TREATMENT OF AA

Chairs: S. Nakao, P. Scheinberg

Special Lecture: The treatment of AA
N.S. Young
Debate: is hATG the only ATG preparation? Yes
C. Dufour
Debate: is hATG the only ATG preparation? No
A. Bacigalupo

ELTROMBOPAG: EMERGING DATA IN BMF

Chairs: C. Selleri, N.S. Young

Eltrombopag in AA: the US experience
P. Scheinberg
Eltrombopag and IST: the EU experience
R. Peffault de Latour
Eltrombopag and MDS: is there any room?
R. Latagliata
Keynote Lecture: The new era of complement inhibition for PNH
A.M. Risitano

NON-TRANSPLANT TREATMENT OF PNH - Proximal complement inhibitors

Chairs: T. Kinoshita, L. Luzzatto

Anti-Factor D: ACH-4471
A.G. Kulasekararaj
Anti-Factor B: LNP023
A.M. Risitano

HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR AA AND PNH

Chairs: J.R. Passweg, R. Peffault de Latour

HSCT for pediatric AA
C. Dufour
HSCT for adults AA
A. Bacigalupo
HSCT for PNH
R. Peffault de Latour

NOVEL STRATEGIES OF TRANSPLANTATION

Chairs: A. Bacigalupo, C. Dufour

The FCC platform and haplo PT-Cy
A. Pagliuca
Cord blood transplantation
A. Ruggeri

ROUND TABLE: THE FUTURE TRIALS FOR AA

Chairs: R.T. Calado, R. Peffaut de Latour, A.M. Risitano, P. Scheinberg, N.S. Young

Proposals from the SAAWP of the EBMT
R. Peffault de Latour, A.M. Risitano
Proposals from the South America AA group
R.T. Calado, P. Scheinberg
Proposals from the NIH
N.S. Young

Studio E.R. Congressi s.r.l.
Via de' Poeti, 1
40124 Bologna BO
P.IVA 06301101009